Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- SARS COV2
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Sample preparation, serum separation by centrifugation 100 µl of serum for standard SARS-CoV2 ELISA is used according to the instructions for use. 100 µl of serum indirect immunofluorescent (IIF) method is used, the samples thus prepared analysis is performed under an automated microscope
Sample preparation, serum separation by centrifugation 100 µl of serum for standard SARS-CoV2 ELISA is used according to the instructions for use. 100 µl of serum indirect immunofluorescent (IIF) method is used, the samples thus prepared analysis is performed under an automated microscope
Tracking Information
- NCT #
- NCT04429620
- Collaborators
- Bilogical Research Centre, Szeged
- Investigators
- Principal Investigator: Katalin Burián, MD University of Szeged, Institute of Clinical Microbilogy
Get Well Soon